In renal cell carcinoma (RCC), POSTN emerges as a key regulator, where its knockdown significantly suppresses epithelial-mesenchymal transition (EMT) through the IKL/AKT/mTOR pathway. This evidence concerns the gene MTOR and renal cell carcinoma.